Cargando…
Local immune and microbiological responses to mucosal administration of a Liposome-TLR agonist immunotherapeutic in dogs
BACKGROUND: Non-specific immunotherapeutics have been evaluated previously in dogs, primarily for cancer treatment. However, there remains a need for a more broadly targeted, general purpose immunotherapeutic capable of activating innate immune defenses for non-specific protection or early treatment...
Autores principales: | Wheat, William, Chow, Lyndah, Kuzmik, Alana, Soontararak, Sirikul, Kurihara, Jade, Lappin, Michael, Dow, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743184/ https://www.ncbi.nlm.nih.gov/pubmed/31519215 http://dx.doi.org/10.1186/s12917-019-2073-8 |
Ejemplares similares
-
Canine polarized macrophages express distinct functional and transcriptomic profiles
por: Chow, Lyndah, et al.
Publicado: (2022) -
Activated Mesenchymal Stromal Cell Therapy for Treatment of Multi-Drug Resistant Bacterial Infections in Dogs
por: Johnson, Valerie, et al.
Publicado: (2022) -
Activation of upper respiratory tract mucosal innate immune responses in cats by liposomal toll‐like receptor ligand complexes delivered topically
por: Wheat, William, et al.
Publicado: (2019) -
Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose‐Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model
por: Soontararak, Sirikul, et al.
Publicado: (2018) -
Humoral immune responses against gut bacteria in dogs with inflammatory bowel disease
por: Soontararak, Sirikul, et al.
Publicado: (2019)